Local Wound Infiltration Plus TAP Block Versus Local Wound Infiltration Only

Sponsor
Kyungpook National University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03376048
Collaborator
(none)
108
2
2
24.3
54
2.2

Study Details

Study Description

Brief Summary

The TAP block is typically performed either with ultrasound guidance (TAP-US) or laparoscopic visualization (TAP-LAP): comparison between these two technics showed no differences in pain control and use of opioid analgesics.

The investigators hypothesize that WI is non-inferior to WI + TAP-block with respect to postoperative pain.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Wound infiltration plus TAP
  • Procedure: Wound infiltration
N/A

Detailed Description

In colorectal surgery, laparoscopy and enhanced recovery after surgery (ERAS) programs have significantly improved the short-term outcomes (1). Although the laparoscopic approach reduces pain and recovery time, post-operative pain, nausea and vomiting still represent an issue. In order to reduce opioid related side effects, such as postoperative nausea and vomiting (PONV), constipation and prolonged post-operative ileus, non-opioid based multimodal analgesia have been recently introduced. Although epidural analgesia has gained good success, it does not seem to offer any additional clinical benefits to patients undergoing laparoscopic colorectal surgery compared to alternative analgesic technique within an ERAS program. Both local wound infiltration (WI) and TAP block are common techniques in multimodal postoperative pain treatment, and their association allows to achieve pain control despite a reduced use of opioid analgesics. Furthermore, in a recent single-blind prospective study TAP block resulted superior to wound infiltration alone. The TAP block is typically performed either with ultrasound guidance (TAP-US) or laparoscopic visualization (TAP-LAP): comparison between these two technics showed no differences in pain control and use of opioid analgesics.

The aim of this study is to compare WI + TAP-LAP versus WI alone. The investigators hypothesize that WI is non-inferior to WI + TAP-block with respect to postoperative pain.

Study Design

Study Type:
Interventional
Actual Enrollment :
108 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison of Analgesic Efficacy of Local Wound Infiltration Plus Transversus Abdominis Plane Block and Local Wound Infiltration Only After Laparoscopic Colorectal Resection: a Randomized, Double-blind, Non-inferiority Trial
Actual Study Start Date :
Dec 20, 2017
Actual Primary Completion Date :
Apr 30, 2019
Actual Study Completion Date :
Dec 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Wound infiltration plus TAP

Wound infiltration placed by surgeon + TAP-LAP placed laparoscopically guided by surgeon

Procedure: Wound infiltration plus TAP
TAP block: At the beginning of the main surgical procedure the surgeon will perform a TAP with ropivacaine infiltration, bilaterally in the anterior axillary line, between the costal margin and iliac crest in the intermuscular plane between the internal oblique and transversus abdominis muscles, the anesthesiologist under ultrasound guidance, the surgeon under laparoscopic guidance (two "pops" technique). Wound infiltration : Wound infiltration of ropivacaine will be performed by the surgeon before skin incision.
Other Names:
  • ropivacaine
  • Active Comparator: Wound infiltration

    Wound infiltration placed by surgeon

    Procedure: Wound infiltration
    Wound infiltration of ropivacaine will be performed by the surgeon before skin incision.
    Other Names:
  • ropivacaine
  • Outcome Measures

    Primary Outcome Measures

    1. Pain numerical rating scale (NRS) [within the first 6 hours after surgery]

      Pain NRS during rest and cough NRS scale 0-10: 0, "no pain"; 10, "worst pain imaginable"

    Secondary Outcome Measures

    1. Pain NRS [12, 24, 36, 48, 72 hour after surgery]

      Pain NRS during rest and cough NRS scale 0-10: 0, "no pain"; 10, "worst pain imaginable"

    2. Rescue opioid analgesic requirement [postoperative day 0, 1, 2, 3]

      Overall postoperative rescue of opioid analgesic requirement described by using the Defined Daily Dose

    3. Postoperative nausea and vomiting scale [12, 24, 36, 48, 72 hour after surgery]

      PONV scores (assessed using a 0 - 2 categorical scale; no nausea/ nausea/ vomiting)

    4. Occurrence of prolonged post-operative ileus [8 weeks after surgery]

      Occurrence of prolonged post-operative ileus (assessed using a 0 - 1 categorical scale; no ileus/ileus)

    5. Time to first oral fluid intake [8 weeks after surgery]

      Time to first oral fluid intake after surgery

    6. Time to first oral soft diet [8 weeks after surgery]

      Time to first oral soft diet after surgery

    7. Length of hospital stay [8 weeks after surgery]

      Length of hospital stay after admission

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Aged 18-80 years, either sex

    • Patients scheduled to undergo elective laparoscopic colorectal surgery under general anesthesia

    • Willingness and ability to sign an informed consent document

    Exclusion Criteria:
    • Allergies to anesthetic or analgesic medications

    • Contraindication to the use of locoregional anesthesia

    • Chronic opioid use

    • Coagulopathy, Impaired kidney function, uncontrolled diabetes, psychiatric disorders, severe cardiovascular impairment or chronic obstructive lung disease

    • Necessity of major resection other than colorectal, palliative surgery

    • BMI above 35 kg/m2

    • American Society of Anesthesiologists (ASA) physical status above 3

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Verona Hospital Trust and Colorectal Cancer Center Verona Italy 37134
    2 Kyungpook National University Chilgok Hospital Daegu Korea, Republic of 41404

    Sponsors and Collaborators

    • Kyungpook National University Hospital

    Investigators

    • Principal Investigator: Soo Yeun Park, MD, Kyungpook National University Chilgok Hospital
    • Principal Investigator: Corrado Pedrazzani, MD, University of Verona Hospital Trust and Colorectal Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Soo Yeun Park, Colorectal Cancer Center, Kyungpook National University Chilgok Hospital, Kyungpook National University Hospital
    ClinicalTrials.gov Identifier:
    NCT03376048
    Other Study ID Numbers:
    • KNUHC01
    First Posted:
    Dec 18, 2017
    Last Update Posted:
    Feb 5, 2020
    Last Verified:
    Feb 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 5, 2020